by Jordana Choucair | Nov 12, 2021 | Life Sciences
The FDA announced the recall of more than 2 million at-home COVID-19 tests produced by Ellume due to “higher-than-acceptable” false positive test results. The FDA says there have been 35 reports of false positives, enough for the agency to identify it as a...
by Jordana Choucair | Nov 10, 2021 | Life Sciences
Moderna is asserting that three National Institute of Health (NIH) scientists were not involved in inventing the key component of its COVID-19 vaccine. According to a filing with the U.S. Patent and Trademark Office, Moderna said it had “reached the good-faith...
by Jordana Choucair | Nov 10, 2021 | Life Sciences
Pfizer asked federal regulators to authorize booster shots of its COVID-19 vaccine for all adults. The FDA is expected to grant the request, perhaps before Thanksgiving and well ahead of the Christmas holiday. The prospect of all 181 million fully vaccinated adults in...
by Jordana Choucair | Nov 9, 2021 | Life Sciences
Pfizer is expected to seek FDA authorization as soon as this week for a booster shot for people 18 and older. According to three officials, the agency is likely to clear the shots. The move could increase booster rates at a time when COVID-19 cases and deaths appear...
by Jordana Choucair | Nov 9, 2021 | Life Sciences
Merck & Co. announced that the federal government will buy another $1 billion worth its COVID-19 pill called molnupiravir. The government spent $1.2 billion on 1.7 million courses of the drug in June and is now exercising its option to buy 1.4 million more. In...
by Jordana Choucair | Nov 8, 2021 | Life Sciences
Regeneron Pharmaceuticals Inc. said its COVID-19 antibody cocktail offered long-term protection to patients in a late-stage trial. According to the drug manufacturer, there were no hospitalizations for COVID-19 in the REGEN-COV group during the eight-month assessment...
Recent Comments